Literature DB >> 2552910

In vitro activities of daptomycin and other antimicrobial agents against vancomycin-resistant gram-positive bacteria.

L de la Maza1, K L Ruoff, M J Ferraro.   

Abstract

A comparative evaluation of daptomycin and eight other antimicrobial agents was performed by the agar dilution technique with 56 strains of vancomycin-resistant gram-positive bacteria, including Leuconostoc, Lactobacillus, and Pediococcus spp. Erythromycin, deptomycin, clindamycin, and gentamicin exhibited the greatest activities, whereas penicillin, ampicillin, and cefotaxime showed moderate activities. The organisms were all highly resistant to vancomycin and cefoxitin.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2552910      PMCID： PMC172660          DOI： 10.1128/AAC.33.8.1383

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  10 in total

1.  Inhibition of peptidoglycan biosynthesis in gram-positive bacteria by LY146032.

Authors:  N E Allen; J N Hobbs; W E Alborn
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

Review 2.  Clinical manifestations and therapy of Lactobacillus endocarditis: report of a case and review of the literature.

Authors:  J I Sussman; E J Baron; S M Goldberg; M H Kaplan; R A Pizzarello
Journal:  Rev Infect Dis       Date:  1986 Sep-Oct

3.  Infection with vancomycin-resistant "streptococci" due to Leuconostoc species.

Authors:  L G Rubin; E Vellozzi; J Shapiro; H D Isenberg
Journal:  J Infect Dis       Date:  1988-01       Impact factor: 5.226

4.  Catheter-associated infection with a vancomycin-resistant gram-positive coccus of the Leuconostoc sp.

Authors:  S Hardy; K L Ruoff; E A Catlin; J Ignacio Santos
Journal:  Pediatr Infect Dis J       Date:  1988-07       Impact factor: 2.129

5.  Leuconostoc, an emerging vancomycin-resistant pathogen.

Authors:  H W Horowitz; S Handwerger; K G van Horn; G P Wormser
Journal:  Lancet       Date:  1987-12-05       Impact factor: 79.321

6.  Vancomycin-resistant leuconostocs, lactobacilli and now pediococci.

Authors:  G Colman; A Efstratiou
Journal:  J Hosp Infect       Date:  1987-07       Impact factor: 3.926

7.  Meningitis caused by vancomycin-resistant Leuconostoc sp.

Authors:  Y M Coovadia; Z Solwa; J van den Ende
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

8.  Vancomycin-resistant gram-positive bacteria isolated from human sources.

Authors:  K L Ruoff; D R Kuritzkes; J S Wolfson; M J Ferraro
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

9.  Odontogenic infection secondary to Leuconostoc species.

Authors:  H S Wenocur; M A Smith; E M Vellozzi; J Shapiro; H D Isenberg
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

10.  Vancomycin-resistant streptococci or Leuconostoc sp.

Authors:  A Buu-Hoï; C Branger; J F Acar
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191
  10 in total
  12 in total

1.  Characterization and antibiotic susceptibility of Pediococcus acidilactici strains isolated from neutropenic patients.

Authors:  J Maugein; P Crouzit; P Cony Makhoul; J Fourche
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

2.  Evaluation of new broth media for microdilution antibiotic susceptibility testing of Lactobacilli, Pediococci, Lactococci, and Bifidobacteria.

Authors:  Ingo Klare; Carola Konstabel; Sibylle Müller-Bertling; Rolf Reissbrodt; Geert Huys; Marc Vancanneyt; Jean Swings; Herman Goossens; Wolfgang Witte
Journal:  Appl Environ Microbiol       Date:  2005-12       Impact factor: 4.792

Review 3.  Current perspectives on glycopeptide resistance.

Authors:  N Woodford; A P Johnson; D Morrison; D C Speller
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

4.  Antimicrobial susceptibility of vancomycin-resistant Leuconostoc, Pediococcus, and Lactobacillus species.

Authors:  J M Swenson; R R Facklam; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

5.  In vitro activity of the trinem sanfetrinem (GV104326) against gram-positive organisms.

Authors:  K V Singh; T M Coque; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

6.  Differential increased survival of staphylococci and limited ultrastructural changes in the core of infected fibrin clots after daptomycin administration.

Authors:  M J Michiels; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

7.  Isolation of vancomycin-resistant enterococci in haematologic patients.

Authors:  H F Guiot; W E Peetermans; F W Sebens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-01       Impact factor: 3.267

8.  Use of multivariate analysis to compare antimicrobial agents on the basis of in vitro activity data.

Authors:  J M Hernández; P Conforti
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

9.  In vitro pharmacodynamic effects of concentration, pH, and growth phase on serum bactericidal activities of daptomycin and vancomycin.

Authors:  K C Lamp; M J Rybak; E M Bailey; G W Kaatz
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

10.  Teicoplanin and daptomycin bactericidal activities in the presence of albumin or serum under controlled conditions of pH and ionized calcium.

Authors:  K C Lamp; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.